Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study
- 1 March 2021
- journal article
- letter
- Published by Elsevier in Joint Bone Spine
- Vol. 88 (2) , 105088
Abstract
No abstract availableFunding Information
- Swedish Orphan Biovitrum
This publication has 8 references indexed in Scilit:
- Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 casesClinical Rheumatology, 2018
- Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: A report of 16 cases and review of the literatureJoint Bone Spine, 2013
- Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritisJoint Bone Spine, 2012
- Interleukin 1β Blockade Improves Signs and Symptoms of Chronic Calcium Pyrophosphate Crystal Arthritis Resistant to TreatmentJCR: Journal of Clinical Rheumatology, 2012
- Efficacy of anakinra in articular chondrocalcinosis: Report of three casesJoint Bone Spine, 2012
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failureJoint Bone Spine, 2009
- Successful treatment of resistant pseudogout with anakinraArthritis & Rheumatism, 2008
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006